Golden State Equity Partners Sangamo Therapeutics, Inc Transaction History

Golden State Equity Partners

$569 Million
Q3 2025

A detailed history of Golden State Equity Partners transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Golden State Equity Partners holds 418,943 shares of SGMO stock, worth $184,334. This represents 0.05% of its overall portfolio holdings.

Number of Shares

418,943

Previous 391,943 6.89%

Holding current value

$184,334

Previous $211,000 32.7%

% of portfolio

0.05%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 21, 2025	BUY	$0.44 - $0.7 $11,880 - $18,900	27,000 Added 6.89%	418,943 $280,000
Q2 2025 Jul 14, 2025	BUY	$0.43 - $0.81 $8,600 - $16,200	20,000 Added 5.38%	391,943 $211,000
Q1 2025 Apr 23, 2025	BUY	$0.66 - $1.37 $30,530 - $63,374	46,259 Added 14.2%	371,943 $245,000
Q4 2024 Jan 24, 2025	BUY	$0.78 - $2.87 $244,597 - $899,994	313,587 Added 2592.27%	325,684 $332,000
Q3 2024 Oct 29, 2024	SELL	$0.32 - $1.1 $81,403 - $279,825	-254,387 Reduced 95.46%	12,097 $10,000

Q3 2024 Oct 25, 2024	BUY	$0.32 - $1.1 $22,197 - $76,304	69,368 Added 35.19%	266,484 $229,000
Q2 2024 Jul 29, 2024	SELL	$0.36 - $0.65 $1,479 - $2,670	-4,109 Reduced 2.04%	197,116 $70,000
Q4 2023 Feb 02, 2024	BUY	$0.3 - $0.63 $10,488 - $22,024	34,960 Added 21.03%	201,225 $108,000
Q3 2023 Oct 20, 2023	BUY	$0.58 - $1.47 $17,690 - $44,835	30,500 Added 22.47%	166,265 $99,000
Q1 2023 Jun 01, 2023	SELL	$1.66 - $3.67 $30,867 - $68,243	-18,595 Reduced 12.05%	135,765 $239 Million
Q1 2022 May 18, 2022	BUY	$5.23 - $7.82 $145,142 - $217,020	27,752 Added 21.92%	154,360 $897,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $89,746 - $134,191	-17,160 Reduced 11.94%	126,608 $1.59 Million
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $118,119 - $177,746	16,203 Added 12.7%	143,768 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $2,315 - $3,086	257 Added 0.2%	127,565 $1.15 Million
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $7,119 - $8,848	700 Added 0.55%	127,308 $1.52 Million
Q1 2021 May 13, 2021	BUY	$10.88 - $17.05 $30,366 - $47,586	2,791 Added 2.25%	126,608 $1.59 Million
Q4 2020 Feb 08, 2021	BUY	$9.23 - $18.18 $1.14 Million - $2.25 Million	123,817 New	123,817 $1.93 Million

Others Institutions Holding SGMO

# of Institutions

124

Shares Held

62.5M

Call Options Held

953K

Put Options Held

1.11M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $68.9M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.

Account

Golden State Equity Partners Sangamo Therapeutics, Inc Transaction History